No items in cart
E-SERIES Product Line Launching
DAVIS, CALIFORNIA, Dec 21, 2021 – ELEVAI Labs, Inc. (“ELEVAI”) is pleased to announce the much anticipated launch of its E-SERIES™ line of products. The E-SERIES is our post-treatment skincare line developed specifically for use following in-office aesthetic procedures.
ELEVAI’s E-SERIES product line includes skincare formulations to support and enhance the results of in-office aesthetic procedures including micro-needling, laser resurfacing, microdermabrasion, and chemical peels. The E-SERIES products will be available only through selected dermatologists, plastic surgeons, and aestheticians in the United States.
ELEVAI was founded by Dr. Jordan Plews, a Stanford-trained scientist, and Dr. Tim Sayed, a Harvard-trained plastic surgeon. The E-SERIES products were developed by the co-founders and are based on proprietary mesenchymal stem cell (MSC) exosome technology, and backed by clinical data. The E-SERIES line is manufactured in the United States by trained scientists at ELEVAI’s labs in Davis, California.
Chief Executive Officer and co-founder of ELEVAI, Dr. Jordan Plews, stated, “We are excited to launch the new ELEVAI Post-Treatment E-SERIES skincare line, bringing the very latest in stem cell exosome technology to skincare and delivering results you can clearly see and feel.”
The E-SERIES products contain exosomes developed using ELEVAI’s patent pending MSC technology. ELEVAI Exosomes are ultra small, nanoparticle compartments packed with growth factors known to support skin health. The new E-SERIES product line includes two products containing ELEVAI ExosomesTM to support skin health: Empower, an after-treatment serum, and Enfinity, a continuing care serum.
Empower is a clean, concentrated serum with potent ELEVAI ExosomesTM as its main ingredient, specifically designed for one-time application post-procedure. Empower is powerful enough to promote and support skin recovery but gentle enough for even sensitive skin.
Enfinity is a rejuvenating serum for at-home daily use following in-office treatment. It contains an effective blend of ELEVAI ExosomesTM combined with stem cell growth factors, hyaluronic acid, copper peptides, collagen-boosting peptides, and a blend of vitamin C designed for increased bioavailability, boosting collagen, and nourishing the skin while combating the signs of aging.
ELEVAI LABS, INC. is a biotechnology company developing cutting-edge regenerative skincare applications. The company solves unmet needs in the regenerative aesthetics space through a combination of cutting-edge science and next-generation consumer applications. ELEVAI Labs develops state-of-the-art topical aesthetic and medical-grade skin care for the physician-dispensed market, with a focus on leveraging a proprietary stem cell exosome technology.
Chief Marketing Officer